MowibbleI believe we will see prices under 2 cents next week.Buy side is very weak and the quarterly shows very little cash in the kittie.Capital raising is just around the corner and that wont attract a great price given the low SP.Rob
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come